Brokerages Set Owens & Minor, Inc. (NYSE:OMI) Target Price at $20.00

Shares of Owens & Minor, Inc. (NYSE:OMI) have been assigned a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $20.00.

OMI has been the topic of a number of analyst reports. Citigroup upgraded Owens & Minor from a “neutral” rating to a “buy” rating and lowered their price target for the company from $24.00 to $19.00 in a research report on Friday, July 19th. StockNews.com lowered Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Robert W. Baird cut their price target on Owens & Minor from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 16th. Barclays cut their price target on Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Monday, August 5th. Finally, Bank of America cut their price target on Owens & Minor from $18.00 to $16.00 and set an “underperform” rating on the stock in a research note on Tuesday, June 25th.

Hedge Funds Weigh In On Owens & Minor

Several institutional investors have recently modified their holdings of OMI. Deerfield Management Company L.P. Series C increased its stake in Owens & Minor by 30.6% in the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock valued at $86,014,000 after acquiring an additional 1,493,852 shares during the last quarter. Norges Bank bought a new position in shares of Owens & Minor during the fourth quarter valued at about $9,160,000. Dimensional Fund Advisors LP grew its stake in shares of Owens & Minor by 8.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,210,991 shares of the company’s stock valued at $81,148,000 after buying an additional 327,002 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Owens & Minor by 16.5% during the second quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock valued at $16,829,000 after buying an additional 176,250 shares during the last quarter. Finally, Lord Abbett & CO. LLC bought a new position in shares of Owens & Minor during the first quarter valued at about $4,683,000. 98.04% of the stock is owned by institutional investors.

Owens & Minor Stock Performance

OMI opened at $16.05 on Thursday. The stock has a market cap of $1.23 billion, a PE ratio of -31.47, a P/E/G ratio of 0.47 and a beta of 0.39. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.17. Owens & Minor has a 1 year low of $12.36 and a 1 year high of $28.35. The stock’s 50 day simple moving average is $15.30 and its 200-day simple moving average is $19.07.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Friday, August 2nd. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.03. The business had revenue of $2.67 billion for the quarter, compared to analysts’ expectations of $2.65 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. Owens & Minor’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.18 earnings per share. Sell-side analysts forecast that Owens & Minor will post 1.57 EPS for the current year.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.